Home

Filing ID: 2538729

PDF: https://cal-access.sos.ca.gov/PDFGen/pdfgen.prg?filingid=2538729&amendid=1

Table: cvr2_registration

filing_id		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729		2538729
amend_id		0		0		0		0		0		0		0		0		0		0		0		0		1		1		1		1		1		1		1		1		1		1		1		1		1
line_item		1		2		3		4		5		6		7		8		9		10		11		12		1		2		3		4		5		6		7		8		9		10		11		12		13
rec_type		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2		CVR2
form_type		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603		F603
tran_id		1		2		3		4		5		6		7		8		9		10		11		12		8772		8773		8774		8775		8776		8777		8778		8779		8780		8781		8782		8783		8784
entity_cd		EMP		FRM		AGY		AGY		AGY		AGY		AGY		AGY		AGY		AGY		AGY		AGY		EMP		FRM		AGY		AGY		AGY		AGY		AGY		AGY		AGY		AGY		AGY		AGY		AGY
entity_id		1382597		1423801		None		None		None		None		None		None		None		None		None		None		1382597		1275439		None		None		None		None		None		None		None		None		None		None		None
enty_naml		Laca		Valencia Government Relations, Inc.		Governor		CHHSA		DHCS		CDPH		DMHC		CDCR		DGS		CalRecycle		CA State Board of Pharmacy		CA Health Benefits Exchange		LACA		CARPENTER SIEVERS LLC		GOVERNOR'S OFFICE		CA HEALTH AND HUMAN SERVICES AGENCY		DEPARTMENT OF HEALTH CARE SERVICES		CA DEPARTMENT OF PUBLIC HEALTH		DEPARTMENT OF MANAGED HEALTH CARE		CA DEPARTMENT OF CORRECTIONS AND REHABILITATION		DEPARTMENT OF GENERAL SERVICES (DGS)		CALRECYCLE		CA STATE BOARD OF PHARMACY		CA HEALTH BENEFITS EXCHANGE		LEGISLATURE
enty_namf		Gaspar		None		None		None		None		None		None		None		None		None		None		None		GASPAR		None		None		None		None		None		None		None		None		None		None		None		None
enty_namt		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None
enty_nams		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None		None

Table: cvr_registration

filing_id		2538729		2538729
amend_id		0		1
rec_type		CVR		CVR
form_type		F603		F603
sender_id		E21121		E21121
filer_id		E21121		E21121
entity_cd		LEM		LEM
filer_naml		GLAXOSMITHKLINE		GSK
filer_namf		None		None
filer_namt		None		None
filer_nams		None		None
report_num		000		001
rpt_date		2020-12-28 00:00:00		2022-05-26 00:00:00
ls_beg_yr		2021		2021
ls_end_yr		2022		2022
qual_date		None		None
eff_date		None		None
bus_city		SACRAMENTO		SACRAMENTO
bus_st		CA		CA
bus_zip4		95814		95811
bus_phon		9167018999		(916) 273-1080
bus_fax		9164471144		None
bus_email		GASPAR.X.LACA@GSK.COM		None
mail_city		SACRAMENTO		None
mail_st		CA		None
mail_zip4		95814		None
mail_phon		None		None
sig_date		2020-12-06 00:00:00		2022-05-26 00:00:00
sig_loc		None		SACRAMENTO, CA
sig_naml		Laca		LACA
sig_namf		Gaspar		GASPAR
sig_namt		None		None
sig_nams		None		None
prn_naml		Laca		LACA
prn_namf		Gaspar		GASPAR
prn_namt		None		None
prn_nams		None		None
sig_title		Government Regional Account Director		GOVERNMENT REGIONAL ACCOUNT DIRECTOR
stmt_firm		None		None
ind_cb		None		None
bus_cb		X		X
trade_cb		None		None
oth_cb		None		None
a_b_name		None		None
a_b_city		None		None
a_b_st		None		None
a_b_zip4		None		None
descrip_1		None		Pharmaceutical research, development, manufacturing and sales
descrip_2		Pharmaceutical research, development, manufacturing and sales.		None
c_less50		None		None
c_more50		None		None
ind_class		HEA		HEA
ind_descr		None		None
bus_class		None		None
bus_descr		None		None
auth_name		None		None
auth_city		None		None
auth_st		None		None
auth_zip4		None		None
lobby_int		Legislative and regulatory issues relating to pharmaceutical & biomedical research, development, manufacturing & sales.		Legislative and regulatory issues to pharmaceutical & biomedical research, development, manufacturing
influen_yn		Y		Y
firm_name		None		None
newcert_cb		None		None
rencert_cb		None		None
complet_dt		None		None
lby_reg_cb		None		None
lby_604_cb		None		None
st_leg_yn		None		None
st_agency		None		None
lobby_cb		None		None
l_firm_cb		None		None

Table: filer_filings

filer_id		1146905		1146905
filing_id		2538729		2538729
period_id		244		250
form_id		F603		F603
filing_sequence		0		1
filing_date		2020-12-28 00:00:00		2022-06-08 00:00:00
stmnt_type		10001		10002
stmnt_status		11001		11003
session_id		2021		2021
user_id		CVANLIEW		CAFILER
special_audit		11003		11003
fine_audit		11003		11003
rpt_start		2020-12-28 00:00:00		2022-05-26 00:00:00
rpt_end		2020-12-28 00:00:00		2022-05-26 00:00:00
rpt_date		None		None
filing_type		22006		22001

Table: filings

filing_id		2538729
filing_type		22001

Table: hdr

filing_id		2538729		2538729
amend_id		0		1
rec_type		HDR		HDR
ef_type		CAL		CAL
state_cd		CA		CA
cal_ver		2.01		2.01
soft_name		CAL-ACCESS OBJECT MODEL		NETFILE
soft_ver		1.00		1809
hdrcomment		None		None

Table: lobby_amendments

filing_id		2538729
amend_id		1
rec_type		F605
form_type		F603
exec_date		2022-05-26 00:00:00
from_date		2021-01-01 00:00:00
thru_date		2022-12-31 00:00:00
add_l_cb		None
add_l_eff		None
a_l_naml		None
a_l_namf		None
a_l_namt		None
a_l_nams		None
del_l_cb		None
del_l_eff		None
d_l_naml		None
d_l_namf		None
d_l_namt		None
d_l_nams		None
add_le_cb		None
add_le_eff		None
a_le_naml		None
a_le_namf		None
a_le_namt		None
a_le_nams		None
del_le_cb		None
del_le_eff		None
d_le_naml		None
d_le_namf		None
d_le_namt		None
d_le_nams		None
add_lf_cb		None
add_lf_eff		None
a_lf_name		None
del_lf_cb		None
del_lf_eff		None
d_lf_name		None
other_cb		X
other_eff		2022-01-01 00:00:00
other_desc		SEE ATTACHMENT A
f606_yes		None
f606_no		X